Table III.
Factors | B | HR | 95% CI | P-value |
---|---|---|---|---|
Gender | ||||
Male (ref.) | 1 | 0.15 | ||
Female | -1.10 | 0.33 | (0.07–1.53) | |
Vascular invasion | ||||
No (ref.) | 1 | 0.007a | ||
Yes | 1.60 | 4.96 | (1.55–15.90) | |
Surgical margin (mm) | ||||
≤1 (ref.) | 1 | 0.17 | ||
>1 | -0.82 | 0.43 | (0.13–1.45) | |
BCLC stage | ||||
0 (ref.) | 1 | 0.62 | ||
A | 0.23 | 1.26 | (0.34–4.55) | |
B | 0.60 | 1.83 | (0.51–6.49) |
STATISTICALLY SIGNIFICANT. HR, hazard ratio; CI, confidence interval; BCLC, Barcelona-Clinic Liver Cancer.